These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17182369)
1. TP63 gene in stress response and carcinogenesis: a broader role than expected. Petitjean A; Hainaut P; Caron de Fromentel C Bull Cancer; 2006 Dec; 93(12):E126-35. PubMed ID: 17182369 [TBL] [Abstract][Full Text] [Related]
2. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231 [TBL] [Abstract][Full Text] [Related]
4. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390 [TBL] [Abstract][Full Text] [Related]
5. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas. Chen YK; Hsue SS; Lin LM Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414 [TBL] [Abstract][Full Text] [Related]
6. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress. Yao JY; Chen JK Biochem Biophys Res Commun; 2010 Dec; 403(3-4):310-5. PubMed ID: 21075072 [TBL] [Abstract][Full Text] [Related]
7. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249 [TBL] [Abstract][Full Text] [Related]
8. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms. Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751 [TBL] [Abstract][Full Text] [Related]
9. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. Boldrup L; Coates PJ; Gu X; Nylander K J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121 [TBL] [Abstract][Full Text] [Related]
10. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate. Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836 [TBL] [Abstract][Full Text] [Related]
11. [The two faces of p63, Janus of the p53 gene family]. Caron de Fromentel C; Aberdam E; Aberdam D Med Sci (Paris); 2012 Apr; 28(4):381-7. PubMed ID: 22549865 [TBL] [Abstract][Full Text] [Related]
12. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation. Ichikawa T; Suenaga Y; Koda T; Ozaki T; Nakagawara A Oncogene; 2008 Jan; 27(4):409-20. PubMed ID: 17637746 [TBL] [Abstract][Full Text] [Related]
13. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Tomkova K; Tomka M; Zajac V Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649 [TBL] [Abstract][Full Text] [Related]
14. A dominant negative form of p63 inhibits apoptosis in a p53-independent manner. Lee HO; Lee JH; Choi E; Seol JY; Yun Y; Lee H Biochem Biophys Res Commun; 2006 May; 344(1):166-72. PubMed ID: 16616891 [TBL] [Abstract][Full Text] [Related]
15. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice. Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK Cancer Res; 2001 Sep; 61(17):6467-73. PubMed ID: 11522642 [TBL] [Abstract][Full Text] [Related]
17. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262 [TBL] [Abstract][Full Text] [Related]
18. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach. Birkaya B; Ortt K; Sinha S BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitous p63 expression in human esophageal squamous cell carcinoma. Hara T; Kijima H; Yamamoto S; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Takazawa K; Tanaka M; Inokuchi S; Makuuchi H Int J Mol Med; 2004 Aug; 14(2):169-73. PubMed ID: 15254760 [TBL] [Abstract][Full Text] [Related]
20. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Barbieri CE; Tang LJ; Brown KA; Pietenpol JA Cancer Res; 2006 Aug; 66(15):7589-97. PubMed ID: 16885358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]